# Allosteros Therapeutics Inc.: Form D filings

Allosteros Therapeutics Inc., a biotechnology company in Palo Alto, United States, filed 2 Form D notices with the SEC between 2010 and 2012. The latest, on August 24, 2012, reports $286,000 sold of a $286,000 offering to 1 investor.

Find out what Allosteros Therapeutics Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Allosteros%20Therapeutics%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Allosteros%20Therapeutics%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fallosteros-therapeutics-inc-1503753)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Allosteros%20Therapeutics%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Allosteros%20Therapeutics%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fallosteros-therapeutics-inc-1503753)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology
- [Form D filings](https://specstream.ai/data/form-d): 44,302 rows, by operating companies, filed since November 1, 2024, $523.02, or the new rows each week for $92.05 a month. Buy: https://specstream.ai/data/form-d

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 560 PENA COURT, Palo Alto, United States, 94306
- Phone: (650) 644-7559
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2009
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1503753

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Aug 24, 2012 | New notice | $286,000 | $286,000 | $0 | 1 | Aug 1, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1503753/000150375312000001/0001503753-12-000001-index.htm) |
| Oct 18, 2010 | New notice | $1,025,000 | $1,025,000 | $0 | 1 | Apr 7, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1503753/000150375310000001/0001503753-10-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Howard Schulman | Executive Officer, Director |  |
| Mark Anderson | Director |  |

[Every Form D from the week of Aug 20, 2012](https://specstream.ai/data/form-d/week/2012-08-20) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Allosteros Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).